Records 1 - 4
| Carboxylesterase 1 polymorphisms are associated with clinical outcomes in gastroenteric cancer patients treated with capecitabine.
Cancer chemotherapy and pharmacology 2021 Feb .
Liu Duo, Li Xuehua, Li Xiang, Wang Huiqi, Dong M
| Impact of DPYD, DPYS, and UPB1 gene variations on severe drug-related toxicity in patients with cancer.
Cancer science 2020 Jul .
Yokoi Katsuyuki, Nakajima Yoko, Matsuoka Hiroshi, Shinkai Yasuko, Ishihara Takuma, Maeda Yasuhiro, Kato Takema, Katsuno Hidetoshi, Masumori Koji, Kawada Kenji, Yoshikawa Tetsushi, Ito Tetsuya, Kurahashi Hiro
| Preliminary Evidence for Enhanced Thymine Absorption: A Putative New Phenotype Associated With Fluoropyrimidine Toxicity in Cancer Patients.
Therapeutic drug monitoring 2018 May .
Duley John A, Ni Ming, Shannon Catherine, Norris Ross L, Sheffield Leslie, Cowley David, Harris Marion, van Kuilenburg André B P, Helsby Nuala, George Rani, Charles Bruce
| Contribution of dihydropyrimidinase gene alterations to the development of serious toxicity in fluoropyrimidine-treated cancer patients.
Cancer chemotherapy and pharmacology 2010 Mar 65 (4): 661-9.
Fidlerova Julie, Kleiblova Petra, Bilek Matej, Kormunda Stanislav, Formankova Zuzana, Novotny Jan, Kleibl Zden